SanaCurrents applies data points to assess how likely a company will be able to advance a drug or device, helping us to determine our decision to potentially buy the stock, which we disclose to members.
SanaCurrents applies data points to assess how likely a company will be able to advance a drug or device, helping us to determine our decision to potentially buy the stock, which we disclose to members.